Bristol-Myers Squibb Co (NYSE:BMY)
| 64.68 Delayed Data As of May 05 |  +0.73 / +1.14%Today’s Change | 54.07 Today|||52-Week Range 67.16 | +4.27% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $139.4B |
Company Description
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Contact Information
Bristol Myers Squibb Co. 430 East 29th Street New York New York 10016 |
Employees
Shareholders
| Mutual fund holders | 39.32% |
| Other institutional | 36.99% |
| Individual stakeholders | 0.33% |
Top Executives
| Giovanni Caforio | Chairman & Chief Executive Officer |
| David V. Elkins | Chief Financial Officer & Executive Vice President |
| Paul von Autenried | Chief Information Officer & Executive VP |
| Rupert J. Vessey | Executive VP-Research & Early Development |
| Joseph E. Eid | Senior VP & Head-Global Medical Affairs |
